Related Articles
Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study
Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF‑κB signaling pathway
Delayed healing and induction of secretory leukocyte protease inhibitor in polycystic ovary syndrome rat skin wounds
Effects of hypoxia‑inducible factor‑1α on endometrial receptivity of women with polycystic ovary syndrome
Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome